Anavex Life Sciences Corp (AVXL)

[nidan7500]

Nice to see AVXL ..."ACT LIKE THEY BELONG IN THE ROOM",

for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases

recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease and a Phase 2 proof-of-concept study in Parkinson’s disease dementia and a Phase 2 study in adult patients with Rett syndrome

Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease.

potential to treat additional CNS disorders, including epilepsy.

The Michael J. Fox Foundation for Parkinson’s Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 for the treatment of Parkinson’s disease.

Changes in public positioning , IMO, demonstrate a subtle but significant change in attitude and status of offerings. Anyone who has been in an organization which presents itself as a "Changed, NEW SELF, Technical Leader ", will see this as a big attitude adjustment.

Attitude Matters, AVXL is expecting to be IN THE ROOM w/Big P and is acting like they EXPECT to be LISTENED TO. IMO, this is a very positive change which should be read by shareholders as a kind of coming out phase as contrasted with wanting to be , "seen but not heard".

IMO, old time shareholders might see this as a subtle and very positive development consistent with ...."We have a story to tell".

IMO, this kind of shift is notable. We should look for and note other changes to follow. These things do NOT JUST HAPPEN, this is a planned organizational change. The reasons should also present themselves shortly, IMO. (as the Irish and the Aussies would say..."ALL THE BEST").

https://www.anavex.com/anavex-life-sciences-announces-participation-at-precision-in-clinical-trials-virtual-summit-west-coast/